Market Overview

Morgan Stanley Hopes for Some Retail Therapy for Humana

Share:
Related HUM
Obama Signs Medicare Bill Encouraging Outcome-Based Compensation
Oppenheimer Boosting Targets In Healthcare On 'Exposure To Interest Rate Changes'
Torchmark Q1 Earnings In Line, 2015 Guidance Narrowed - Analyst Blog (Zacks)

In a report published Thursday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on Humana (NYSE: HUM).

In the report, Morgan Stanley noted, “HUM maintained its 2014 EPS outlook of $7.25 to $7.75, but increased its Medicare Advantage, Part D, and commercial individual enrollment outlook on the heels of 4Q. We have lowered our FY14 EPS by $0.05 to $7.70, which reflects higher revenue from new lives, but a lower overall pre-tax margin.”

Humana closed on Wednesday at $95.71.

Latest Ratings for HUM

DateFirmActionFromTo
Mar 2015BarclaysMaintainsEqual-weight
Jan 2015BarclaysMaintainsEqual-weight
Jan 2015Deutsche BankUpgradesSellHold

View More Analyst Ratings for HUM
View the Latest Analyst Ratings

Posted-In: Andrew Schenker Morgan StanleyAnalyst Color Reiteration Analyst Ratings

 

Related Articles (HUM)

Around the Web, We're Loving...